Sign inGet started

ADAMIS ANTHONY P

Insider CIK 1277479 · EYPT Director · KLRS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KLRS Kalaris Therapeutics, Inc. A Award deriv2026-06-032026-06-049,000— $09,000SEC↗
KLRS Kalaris Therapeutics, Inc. A Award deriv2025-04-102025-04-1118,000— $018,000SEC↗
KLRS Kalaris Therapeutics, Inc. A Award deriv2025-03-182025-03-1819,484— $019,484SEC↗
KLRS Kalaris Therapeutics, Inc. A Award deriv2025-03-182025-03-1812,989— $012,989SEC↗
EYPT EyePoint Pharmaceuticals, M Exercise deriv2024-06-232024-06-252,000— $02,000SEC↗
EYPT EyePoint Pharmaceuticals, M Exercise2024-06-232024-06-252,000— $04,000SEC↗
EYPT EyePoint Pharmaceuticals, A Award deriv2024-01-052024-01-0925,014— $025,014SEC↗
EYPT EyePoint Pharmaceuticals, M Exercise deriv2023-06-232023-06-262,000— $04,000SEC↗
EYPT EyePoint Pharmaceuticals, M Exercise2023-06-232023-06-262,000— $02,000SEC↗
EYPT EyePoint Pharmaceuticals, A Award deriv2023-06-202023-06-2213,000— $013,000SEC↗
EYPT EyePoint Pharmaceuticals, A Award deriv2023-06-202023-06-2226,100— $026,100SEC↗
EYPT EyePoint Pharmaceuticals, A Award deriv2022-06-232022-06-276,000— $06,000SEC↗
EYPT EyePoint Pharmaceuticals, A Award deriv2022-06-232022-06-2722,000— $022,000SEC↗